Correlation Between Apellis Pharmaceuticals and Protalix Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Protalix Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Protalix Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Protalix Biotherapeutics, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Protalix Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Protalix Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Protalix Biotherapeutics.
Diversification Opportunities for Apellis Pharmaceuticals and Protalix Biotherapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Apellis and Protalix is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Protalix Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protalix Biotherapeutics and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Protalix Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protalix Biotherapeutics has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Protalix Biotherapeutics go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Protalix Biotherapeutics
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 2.23 times less return on investment than Protalix Biotherapeutics. But when comparing it to its historical volatility, Apellis Pharmaceuticals is 1.44 times less risky than Protalix Biotherapeutics. It trades about 0.21 of its potential returns per unit of risk. Protalix Biotherapeutics is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest 113.00 in Protalix Biotherapeutics on August 29, 2024 and sell it today you would earn a total of 55.00 from holding Protalix Biotherapeutics or generate 48.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Protalix Biotherapeutics
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Protalix Biotherapeutics |
Apellis Pharmaceuticals and Protalix Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Protalix Biotherapeutics
The main advantage of trading using opposite Apellis Pharmaceuticals and Protalix Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Protalix Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protalix Biotherapeutics will offset losses from the drop in Protalix Biotherapeutics' long position.| Apellis Pharmaceuticals vs. Bright Minds Biosciences | Apellis Pharmaceuticals vs. HP Inc | Apellis Pharmaceuticals vs. Intel | Apellis Pharmaceuticals vs. Chevron Corp |
| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |